Larvol Cliniclarvol.hashnode.dev·Jul 18, 2024An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have SpreadBrief Summary The purpose of this study is to demonstrate the safety and preliminary activity with triple combinations of relatlimab in combination with nivolumab and BMS-986205, or in combination with nivolumab and ipilimumab in immunotherapy-naive ...GoogleAdd a thoughtful commentNo comments yetBe the first to start the conversation.